KARA LAUKO MASTERSON AGACNP
Prescription History 1497274856
Nurse Practitioner - Acute Care in Los Angeles, CA

Active since September 16, 2017PECOS EnrolledAccepts Medicare Assignment
75.48/100
CMS Quality Rating
757 WESTWOOD PLZ, LOS ANGELES, CA 90095(310) 267-9793 Get Directions

NPPES record last updated: April 17, 2023. Verified against the NPPES registry weekly; last sync: October 25, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for KARA LAUKO MASTERSON AGACNP, an active Acute Care specialist practicing in Los Angeles, CA. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 13 documented patient claims. Among these therapy options, the most frequently utilized medication is Tranexamic Acid, which accounts for 13 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
13
Total Claims
13
30-Day Fills
Tranexamic Acid
Most Prescribed · 13 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by KARA LAUKO MASTERSON AGACNP in 2024, with prescription volumes, average cost per fill, and CA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other CA PrescribersVs. CA Avg
Tranexamic Acid13$68.56▼ Less than typical

About Tranexamic Acid: This medication is used to treat heavy bleeding during your menstrual period. Show more ▾

Tranexamic acid works by slowing the breakdown of blood clots, which helps to prevent prolonged bleeding. It belongs to a class of drugs known as antifibrinolytics. Tranexamic acid is not a hormone. It does not treat other menstrual or pre-menstrual symptoms. It does not stop your period. It is not a form of birth control and does not protect against sexually transmitted diseases. Antifibrinolytic hemostatic used in severe hemorrhage.

In 2024, this provider wrote 13 Medicare prescriptions for Tranexamic Acid, about half the volume of the typical California prescriber of this medication (30.1). Medicare paid an average of $68.56 per fill, versus $56.46 statewide.

How often this provider prescribes it

This provider
13
CA average
30.1

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$68.56
CA average
$56.46

Gross Part D cost per fill; not the patient's out-of-pocket price.

13
30-Day Fills
standardized to 30-day supplies
385
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average CA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the CA average cost per fill.

About this data. The prescription history for KARA LAUKO MASTERSON AGACNP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Acute Care prescribing approach at this Los Angeles, CA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.